Table 2.
Clinical application of PSMA–PET/CT
| Primary staging | Comparison with mpMRI is preferable because low spatial resolution and artifact given by excreted tracer |
| Secondary staging | Accuracy depends on serum PSA level |
| Diagnosis of biochemical recurrence | Accuracy depends on serum PSA level, Biochemical progression-free survival |
| Treatment planning | Delineation of CTV to include potential occult tumor for SRT |
| Response evaluation | RLT with alpha- or beta-emitting radionucleotides |
Abbreviations: PSMA, prostatic specific membrane antigen; mpMRI, multiparametric magnetic resonance imaging; PSA, prostate specific antigen; CTV, clinical target volume; SRT, stereotactic radiotherapy; RLT, radioligand therapy.